Diabetes Solutions Landscape KPI - Virta
Virta Health is the "first clinically-proven treatment to safely and sustainably reverse type 2 diabetes without medications or surgery." The company has so far been successful, achieving $37 million in Series A and Seed funding and $45 million in Series B funding. I have organized and summarized my findings on Virta Health in the attached spreadsheet. I have provided key performance indicators, as per you request in row 12, columns T-AO.
There was no information regarding FDA approval, but since this treatment plan is more of a ketogenic diet that includes a mobile app and nutritional coaching, rather than a drug or medical device, FDA approval is not necessary. There was also no information publically available on registered users. However the company does claim that they hope to serve 100 million patients by 2025.
KEY PERFORMANCE INDICATORS
- 94% of insulin users reduced or eliminated insulin usage after one year.
- 60% of type 2 diabetes reverse their condition after one year.
- Patients saw an average of a 1.3% HbA1c reduction
after 1 year.
To wrap things, I have completed row 12, columns T-AO in the attached spreadsheet and have included information on market access, funding, uptake, user satisfaction and impact regarding the Virta Treatment.